Xconomy | Boston - Business + Technology in the Exponential Economy

Related Posts

deals, Advanced Cell Technology, Embryome Sciences

ACT Licences Pluropotent Cell IP

Ryan McBride 8/21/08

Advanced Cell Technology, a California-based developer of cellular treatments with R&D labs in Worcester, MA, has licensed technology from Embryome Sciences related to the reprogramming of human cells such as skin cells into embryonic-like cells that can differentiate into a variety of cell types, Embryome reports. The technology from Alameda, CA-based Embryome is intended to enable cells with stem cell-like qualities to be generated without the controversial use of human embryos and egg cells.

Comments | Permalink | Share this post Share | E-mail E-mail

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map
Visit a city in our network or go to
Xconomy National
for network hightlights
Seattle Boston San Diego

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.